Date of Presentation
5-4-2023 12:00 AM
College
Rowan-Virtua School of Osteopathic Medicine
Poster Abstract
Xylazine, according to the National Institutes of Health (NIH), is a non-opioid tranquilizer used in veterinary medicine. Although this drug has not been approved for human use, it can be linked to an increase in opioid overdose deaths due to its role as an adulterant in drugs like fentanyl.
Xylazine was detected in drugs involved in 41% of all opioid-involved unintentional deaths and in 44% of all unintentional overdose deaths with fentanyl involved in the year of 2021 in Philadelphia.
Keywords
Xylazine, Fentanyl, Opioids, Drug Adulteration, Substance-Related Disorders
Disciplines
Community Health and Preventive Medicine | Health Services Research | Heterocyclic Compounds | Medicine and Health Sciences | Other Chemicals and Drugs | Pathological Conditions, Signs and Symptoms | Substance Abuse and Addiction
Document Type
Poster
Included in
Community Health and Preventive Medicine Commons, Health Services Research Commons, Heterocyclic Compounds Commons, Other Chemicals and Drugs Commons, Pathological Conditions, Signs and Symptoms Commons, Substance Abuse and Addiction Commons
Growing Use of Xylazine as an Adulterant in Opioids and Its Effects
Xylazine, according to the National Institutes of Health (NIH), is a non-opioid tranquilizer used in veterinary medicine. Although this drug has not been approved for human use, it can be linked to an increase in opioid overdose deaths due to its role as an adulterant in drugs like fentanyl.
Xylazine was detected in drugs involved in 41% of all opioid-involved unintentional deaths and in 44% of all unintentional overdose deaths with fentanyl involved in the year of 2021 in Philadelphia.